The compression therapy devices are used to treat phlebitis, thrombosis and aftercare following surgery, sclerotherapy and any other forms of varicose vein treatment, and also to relieve all conditions of chronic venous disease (heavy legs, varicose veins, oedemas, leg ulcers). Compression therapy is recognized as a gold standard of treatment for lymphedema, chronic venous insufficiency, and deep vein thrombosis due to its advantages being is safe, easy-to-use and they provide effective treatment in a shortest time span. It provides increased venous and lymphatic fluid in the limb through the utilization of external force (exerted by compression products). It can also be prescribed to prevent venous issues during pregnancy and long distance travel.
The global compression therapy devices market report provides market size estimates (Revenue USD million – 2014 to 2021) for key market segments based on the device type (elastic compression bandages, compression pumps, compression stockings, compression tapes, intermittent pneumatic compression, and sequential compression devices), technology (static and dynamic technologies), disease condition (lymphedema, venous thromboembolism, others), and forecasts growth trends (CAGR% – 2017 to 2021).
The global compression therapy devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global compression therapy devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global compression therapy devices market and included in this report are 3M Health Care, ArjoHuntleigh, BSN medical, Getinge Group, Hartmann AG, Medtronic plc, Bio Compression Systems, Inc., medi GmbH & Co. KG, PAUL HARTMANN AG, and SIGVARIS MANAGEMENT AG.